Vantrela ER (Hydrocodone Bitartrate Extended-release Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 26, 2017 Category: Drugs & Pharmacology Source Type: news
Tussigon (Hydrocodone Bitartrate and Homatropine Methylbromide Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 26, 2017 Category: Drugs & Pharmacology Source Type: news
NeuroBreak: Abuse-Deterrent Hydrocodone; Neuroscience of Lying
(MedPage Today) -- News and commentary from the world of neurology and neuroscience (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - January 24, 2017 Category: Geriatrics Source Type: news
Teva Receives FDA Approval for Vantrela ER (hydrocodone bitartrate) Extended-Release Tablets Formulated with Proprietary Abuse Deterrence Technology
JERUSALEM--(BUSINESS WIRE)--Jan. 18, 2017-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the U.S. Food and Drug Administration (FDA) approved Vantrela ER (hydrocodone bitartrate) extended-release tablets [CII] formulated... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 18, 2017 Category: Drugs & Pharmacology Source Type: news
Another Abuse-Deterrent Opioid (Vantrela ER) Gets FDA Nod Another Abuse-Deterrent Opioid (Vantrela ER) Gets FDA Nod
The agency has approved an extended-release hydrocodone product (Vantrela ER) formulated with abuse-deterrent technology, Teva announced.
FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 18, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news
Fentanyl Overdoses Are Rising And Science Can't Keep Up
Bribery. Conspiracy. Racketeering.
Those are just three of the accusations that federal prosecutors leveled against two Alabama physicians in April as part of a 22-count criminal indictment ― alleging that Drs. John Couch and Xiulu Ruan ran an opioid pill mill in exchange for hundreds of thousands of dollars in kickbacks from a pharmaceutical company.
Couch and Ruan were arrested in 2015 after prescribing Medicare patients a combined $4.9 million in Subsys ― a potent form of fentanyl, taken via mouth spray and designed to treat severe cancer pain ― between 2013 and 2014.
Some of those prescription...
Source: Healthy Living - The Huffington Post - January 9, 2017 Category: Consumer Health News Source Type: news
Vicoprofen (Hydrocodone and Ibuprofen) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 9, 2017 Category: Drugs & Pharmacology Source Type: news
Zohydro ER (Hydrocodone bitartrate Extended Release Capsules) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 6, 2017 Category: Drugs & Pharmacology Source Type: news
Oxycodone vs. Vicodin (hydrocodone/acetaminophen)
Title: Oxycodone vs. Vicodin (hydrocodone/acetaminophen)Category: MedicationsCreated: 1/3/2017 12:00:00 AMLast Editorial Review: 1/4/2017 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - January 4, 2017 Category: Anesthesiology Source Type: news
Severe respiratory depression after snorting U-47700
3.5 out of 5 stars
Two cases of intoxication with new synthetic opioid, U-47700. Domanski K et al. Clin Toxicol 2017 Jan;55:46-50.
Abstract
U-47700 was first synthesized by Upjohn in the 1970s — hence the “U”. The company was seeking to develop an analgesic as effective as morphine but not addictive. Work on this compound was abandoned when the addictive properties of the drug became apparent.
U-47700 is a μ-receptor agonist that is approximately 7.5 times as potent as morphine. This paper reports two patients who presented to hospital after insufflating U-47700 (confirmed on laboratory testing.) One pat...
Source: The Poison Review - December 30, 2016 Category: Toxicology Authors: Leon Gussow Tags: Medical synthetic opioid U-47700 Source Type: news
Obredon (Hydrocodone Bitartrate and Guaifenesin Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 29, 2016 Category: Drugs & Pharmacology Source Type: news
New Topic Page: Opioid Abuse and Addiction
Visit the new MedlinePlus Health Topic page on Opioid Abuse and Addiction.
Opioids, sometimes called narcotics, are a type of drug. They include strong prescription pain relievers, such as oxycodone, hydrocodone, fentanyl, and tramadol... (Source: What's New on MedlinePlus)
Source: What's New on MedlinePlus - December 28, 2016 Category: Consumer Health News Source Type: news
Percocet vs. Lortab for Pain
Title: Percocet vs. Lortab for PainCategory: MedicationsCreated: 12/28/2016 12:00:00 AMLast Editorial Review: 12/28/2016 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - December 28, 2016 Category: Anesthesiology Source Type: news
Hycofenix (Hydrocodone Bitartrate, Pseudoephedrine Hydrochloride, and Guaifenesin Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 28, 2016 Category: Drugs & Pharmacology Source Type: news
Garry Shandling Died Of A Blood Clot, According To Autopsy Report
Garry Shandling died from a blood clot, TMZ reported on Tuesday after it obtained a copy of the comedian’s autopsy report. The outlet said that Shandling also had Xanax, hydrocodone and oxycodone in his system at the time, attributed to a recent dentist surgery.
The 66-year-old died earlier this year on March 24. According to the report, Shandling had complained of leg pain and shortness of breath the day before his death.
The Emmy-winning actor was best known for his work on “The Larry Sanders Show” and “It’s Garry Shandling’s Show,” as well as his hilarious c...
Source: Healthy Living - The Huffington Post - December 27, 2016 Category: Consumer Health News Source Type: news
